4.6 Article

Serum vasohibin-1 levels: A potential marker of dermal and pulmonary fibrosis in systemic sclerosis

Related references

Note: Only part of the references are listed.
Article Dermatology

Cyclophosphamide Pulse Therapy Normalizes Vascular Abnormalities in a Mouse Model of Systemic Sclerosis Vasculopathy

Takashi Yamashita et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)

Article Dermatology

A potential contribution of trappin-2 to the development of vasculopathy in systemic sclerosis

T. Miyagawa et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

Review Dermatology

Systemic sclerosis

Yoshihide Asano

JOURNAL OF DERMATOLOGY (2018)

Review Peripheral Vascular Disease

Double-Face of Vasohibin-1 for the Maintenance of Vascular Homeostasis and Healthy Longevity

Yasufumi Sato

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)

Article Dermatology

The impact of transcription factor Fli1 deficiency on the regulation of angiogenesis

Tetsuo Toyama et al.

EXPERIMENTAL DERMATOLOGY (2017)

Review Medicine, General & Internal

Systemic sclerosis

Christopher P. Denton et al.

LANCET (2017)

Article Dermatology

A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis

Takashi Taniguchi et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2017)

Review Immunology

Vasculopathy in scleroderma

Yoshihide Asano et al.

SEMINARS IN IMMUNOPATHOLOGY (2015)

Article Medicine, General & Internal

Systemic sclerosis

Yannick Allanore et al.

NATURE REVIEWS DISEASE PRIMERS (2015)

Article Dermatology

Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis

Yohei Ichimura et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2014)

Article Rheumatology

Serum leptin, resistin and TNF-a levels in patients with systemic sclerosis: the role of adipokines in scleroderma

Yavuz Pehlivan et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2012)

Article Oncology

Vasohibin-1 and vasohibin-2 expression in gastric cancer cells and TAMs

Zhanlong Shen et al.

MEDICAL ONCOLOGY (2012)

Review Pharmacology & Pharmacy

The vasohibin family: Novel regulators of angiogenesis

Yasufumi Sato

VASCULAR PHARMACOLOGY (2012)

Article Immunology

EVALUATION OF THE EFFECT OF BOSENTAN TREATMENT ON PROINFLAMMATORY CYTOKINE SERUM LEVELS IN PATIENTS AFFECTED BY SYSTEMIC SCLEROSIS

F. Bellisai et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2011)

Article Multidisciplinary Sciences

Egr-1 Induces a Profibrotic Injury/Repair Gene Program Associated with Systemic Sclerosis

Swati Bhattacharyya et al.

PLOS ONE (2011)

Article Pathology

Endothelial Fli1 Deficiency Impairs Vascular Homeostasis A Role in Scleroderma Vasculopathy

Yoshihide Asano et al.

AMERICAN JOURNAL OF PATHOLOGY (2010)

Review Rheumatology

Cellular and molecular aspects of vascular dysfunction in systemic sclerosis

Maria Trojanowska

NATURE REVIEWS RHEUMATOLOGY (2010)

Letter Dermatology

Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension

Yasuhito Hamaguchi et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2009)

Review Dermatology

Autocrine TGF-β signaling in the pathogenesis of systemic sclerosis

Hironobu Ihn

JOURNAL OF DERMATOLOGICAL SCIENCE (2008)

Article Pathology

Increased expression levels of integrin αvβ5 on scleroderma fibroblasts

Y Asano et al.

AMERICAN JOURNAL OF PATHOLOGY (2004)

Article Critical Care Medicine

Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent

H Takahashi et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)